{
  "folder": "IC-074",
  "content": "{{knowledge objective\n|Identifiant=OIC-074-19-A\n|Item_parent=Prescription and monitoring of psychotropic drugs (see item 330)\n|Item_parent_short=Prescription and monitoring of psychotropic drugs (see item 330)\n|Rank=A\n|Title=Hypnotics: knowing the rules for correct use at all stages of life, particularly in elderly patients\n|Description=None\n|Rubric=Management\n|Contributors=\n|Order=19}}\n\n\n== '''The prescription''' ==\n\n* Must comply with the ''prescribing rules'' described for ''anxiolytics'';\n* Must be prescribed at the ''minimum effective dose'';\n* Must be prescribed for a ''limited period'' to ''avoid the risk of pharmacological tolerance'' and ''use disorders'' (a few days for reactive insomnia, a few weeks for transient insomnia);\n* Must be limited to ''4 weeks'' for ''hypnotics'';\n* Treatment must not be stopped abruptly;\n* Dosages should be adapted for elderly patients (lower doses);\n* A ''short half-life treatment'' should be chosen for ''insomnia associated with falling asleep'' (as well as in the elderly) and a ''longer half-life treatment'' for ''insomnia during the second half of the night'';\n* Patients should be \"informed\" of the risk of \"potentiation by alcohol consumption\" and the \"risk of drowsiness\" (driving);\n* To limit the risk of misuse, zolpidem must be prescribed on a \"secure prescription\" for a maximum of 28 days.",
  "question": {
    "question": "When prescribing hypnotics, especially to elderly patients, which of the following practices is NOT recommended?",
    "option_a": "Prescribing at the minimum effective dose to avoid tolerance and use disorders.",
    "option_b": "Prescribing for a limited period, such as 4 weeks for hypnotics.",
    "option_c": "Choosing a short half-life treatment for insomnia associated with falling asleep.",
    "option_d": "Prescribing zolpidem on a secure prescription for a maximum of 28 days to limit misuse.",
    "correct_option": "C"
  }
}